Programs

The Defense Production Act (DPA) Title III office is committed to ensuring resilient, robust domestic supply chains to reduce reliance on foreign manufacturing and correct domestic shortfalls in the defense industrial base. The DPA Title III office works in partnership with the Uniformed services, other government agencies, and industry to identify areas where critical industrial capacity is insufficient to meet U.S. defense and commercial needs. The office partners with U.S. private industry to mitigate gaps in the domestic supply chain using grants, purchase commitments, loans, or loan guarantees. The DPA Title III office is comprised of subject matter experts across a wide variety of investment areas, acquisition professionals, skilled program managers, and data analytics and audit professionals.

The Distributed Bioindustrial Manufacturing Program (DBIMP) aims to advance biotechnology as part of efforts to strengthen and build the resiliency of America's defense industrial base and secure its supply chains. Biomanufacturing has the potential to support the U.S. military and our allies and partners by generating needed materials — from fuels and chemicals to food and medical supplies — where and when our forces need them has significant implications for our military. 

The Manufacturing Capability Expansion and Investment Prioritization (MCEIP) Office oversees the execution of the Defense Production Act Investments (DPAI) and Innovation Capability and Modernization (ICAM) portfolios, utilizing all available authorities to address the challenge and incentivize industry.

Manufacturing USA was created in 2014 to secure U.S. global leadership in advanced manufacturing by connecting people, ideas, and technology. Manufacturing USA institutes convene business competitors, academic institutions, and other stakeholders to test applications of new technology, create new products, reduce cost and risk, and enable the manufacturing workforce with the skills of the future.